Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 2/20 | 0.61 |
| ▸ | NPC1 | O15118 | 5/20 | 0.56 |
| ▸ | RAB9A | P51151 | 5/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.56 |
| ▸ | METAP2 | P50579 | 3/20 | 0.54 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.51 |
| ▸ | ADAM17 | P78536 | 3/20 | 0.50 |
| ▸ | BRD4 | O60885 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3323868 | 0.93 | HSD11B1 (0.59) | HSD11B1NPC1RAB9ASMN1; SMN2METAP2 | |
| SCHEMBL13333114 | 0.85 | HSD11B1 (0.59) | HSD11B1SMN1; SMN2METAP2LMNAALDH1A1 | |
| SCHEMBL3319986 | 0.78 | HPGD (0.58) | HSD11B1METAP2LMNAALDH1A1MAPT | |
| SCHEMBL863136 | 0.78 | NPC1 (0.66) | HSD11B1NPC1RAB9ASMN1; SMN2TAAR1 | |
| SCHEMBL20930316 | 0.78 | HSD11B1 (0.53) | HSD11B1NPC1RAB9ASMN1; SMN2METAP2 | |
| SCHEMBL29273913 | 0.77 | SMN1; SMN2 (0.63) | HSD11B1NPC1RAB9ASMN1; SMN2METAP2 | |
| SCHEMBL13333009 | 0.76 | HSD11B1 (1.00) | HSD11B1NPC1RAB9ASMN1; SMN2METAP2 | |
| SCHEMBL2731878 | 0.76 | NPC1 (0.68) | HSD11B1NPC1RAB9ASMN1; SMN2METAP2 | |
| SCHEMBL14491572 | 0.76 | SMN1; SMN2 (0.57) | HSD11B1NPC1RAB9ASMN1; SMN2METAP2 | |
| SCHEMBL3323624 | 0.76 | HSD11B1 (0.70) | HSD11B1NPC1RAB9ASMN1; SMN2METAP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100120789-A1 | Compound | STERIX LIMITED (GB) | 2010-05-13 | — | — | US | disclosed |
| US-20100120789-A1 | Compound | STERIX LIMITED (GB) | 2010-05-13 | — | — | US | disclosed |
| US-20100120789-A1 | Compound | STERIX LIMITED (GB) | 2010-05-13 | — | — | US | disclosed |
| US-20090042929-A1 | 11-Beta-Hydroxysteroid Dehydrogenase Inhibitors | STERIX LIMITED (GB) | 2009-02-12 | — | — | US | disclosed |
| US-20090042929-A1 | 11-Beta-Hydroxysteroid Dehydrogenase Inhibitors | STERIX LIMITED (GB) | 2009-02-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090042929-A1 | 11-Beta-Hydroxysteroid Dehydrogenase Inhibitors | HSD3B1, HSD3B2, HSD11B1 | HSD11B1 3/4885NPC1 1106/4885RAB9A 2432/4885 |
| US-20100120789-A1 | Compound | NR0B2, NR0B1, NR4A1 | HSD11B1 73/4885NPC1 2474/4885RAB9A 2176/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.